IL213164A0 - Inhibitors of diacylglycerol acyltransferase - Google Patents
Inhibitors of diacylglycerol acyltransferaseInfo
- Publication number
- IL213164A0 IL213164A0 IL213164A IL21316411A IL213164A0 IL 213164 A0 IL213164 A0 IL 213164A0 IL 213164 A IL213164 A IL 213164A IL 21316411 A IL21316411 A IL 21316411A IL 213164 A0 IL213164 A0 IL 213164A0
- Authority
- IL
- Israel
- Prior art keywords
- inhibitors
- diacylglycerol acyltransferase
- acyltransferase
- diacylglycerol
- Prior art date
Links
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 title 1
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13815708P | 2008-12-17 | 2008-12-17 | |
| PCT/US2009/068048 WO2010077861A1 (en) | 2008-12-17 | 2009-12-15 | Inhibitors of diacylglycerol aclytransferase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL213164A0 true IL213164A0 (en) | 2011-07-31 |
Family
ID=42241316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL213164A IL213164A0 (en) | 2008-12-17 | 2011-05-26 | Inhibitors of diacylglycerol acyltransferase |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8211914B2 (enExample) |
| EP (1) | EP2378878A4 (enExample) |
| JP (1) | JP2012512252A (enExample) |
| CN (1) | CN102245024A (enExample) |
| AU (1) | AU2009333333A1 (enExample) |
| CA (1) | CA2745445A1 (enExample) |
| IL (1) | IL213164A0 (enExample) |
| WO (1) | WO2010077861A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8153644B2 (en) | 2007-05-22 | 2012-04-10 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8115011B2 (en) | 2007-05-22 | 2012-02-14 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8211884B2 (en) | 2008-08-06 | 2012-07-03 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8324385B2 (en) | 2008-10-30 | 2012-12-04 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| JP2012512252A (ja) | 2008-12-17 | 2012-05-31 | ブイアイエイ・ファーマシューティカルズ・インコーポレーテッド | ジアシルグリセロールアシルトランスフェラーゼの阻害剤 |
| TW201305140A (zh) * | 2011-06-17 | 2013-02-01 | Daiichi Sankyo Co Ltd | 新穎聯芳基醚衍生物 |
| US9527859B2 (en) | 2012-04-13 | 2016-12-27 | Mitsubishi Tanabe Pharma Corporation | Amidopyridine derivative and use thereof |
| MY195016A (en) | 2014-08-04 | 2023-01-03 | Nuevolution As | Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases |
| AR109179A1 (es) | 2016-08-19 | 2018-11-07 | Pfizer | Inhibidores de diacilglicerol aciltransferasa 2 |
| AU2020405446A1 (en) | 2019-12-20 | 2022-05-26 | Nuevolution A/S | Compounds active towards nuclear receptors |
| BR112022012205A2 (pt) | 2019-12-20 | 2022-09-13 | Nuevolution As | Compostos ativos para receptores nucleares |
| JP7713954B2 (ja) | 2020-03-31 | 2025-07-28 | ヌエヴォリューション・アクティーゼルスカブ | 核内受容体に対して活性な化合物 |
| CA3174252A1 (en) | 2020-03-31 | 2021-10-07 | Nuevolution A/S | Compounds active towards nuclear receptors |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3250771A (en) * | 1962-12-17 | 1966-05-10 | Geigy Chem Corp | 5-monocarbocyclic aryl-n-lower alkyl-2-pyrrolidine carboxylic acid, esters, amides and derivatives thereof |
| DE2337461A1 (de) * | 1973-07-24 | 1975-02-06 | Boehringer Mannheim Gmbh | Neue indolderivate und verfahren zu deren herstellung |
| US4066654A (en) * | 1975-04-16 | 1978-01-03 | G. D. Searle & Co. | 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives |
| US6495558B1 (en) * | 1999-01-22 | 2002-12-17 | Amgen Inc. | Kinase inhibitors |
| DE60017115T2 (de) | 1999-02-10 | 2005-12-08 | Mitsubishi Pharma Corp. | Amid-derivate und deren medizinische verwendung |
| US6756374B2 (en) * | 2001-01-22 | 2004-06-29 | Hoffmann-La Roche Inc. | Diaminothiazoles having antiproliferative activity |
| BR0212158A (pt) | 2001-08-31 | 2004-07-13 | Aventis Pharma Gmbh | Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar |
| US7553867B2 (en) | 2002-09-06 | 2009-06-30 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
| EP1562956A4 (en) * | 2002-11-22 | 2007-10-10 | Japan Tobacco Inc | HETEROCYCLES CONTAINING FUSED BICYCLIC NITROGEN |
| US7148246B2 (en) * | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| DE10308353A1 (de) * | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CN101115711A (zh) * | 2005-02-07 | 2008-01-30 | 霍夫曼-拉罗奇有限公司 | 二酰基甘油酰基转移酶(dgat)的抑制剂 |
| CA2610188A1 (en) | 2005-06-11 | 2006-12-21 | Astrazeneca Ab | Oxadiazole derivatives as dgat inhibitors |
| BRPI0619052A2 (pt) | 2005-11-28 | 2011-09-20 | Hoffmann La Roche | compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de diacilglicerol aciltransferase, e seu uso |
| CN101316844A (zh) * | 2005-11-28 | 2008-12-03 | 霍夫曼-拉罗奇有限公司 | 二酰甘油酰基转移酶(dgat)抑制剂 |
| US8058299B2 (en) * | 2007-05-22 | 2011-11-15 | Via Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8115011B2 (en) * | 2007-05-22 | 2012-02-14 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8153644B2 (en) * | 2007-05-22 | 2012-04-10 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US20090099201A1 (en) * | 2007-05-22 | 2009-04-16 | David Robert Bolin | Diacylglycerol Acyltransferase Inhibitors |
| EP2155687A1 (en) | 2007-05-22 | 2010-02-24 | Via Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US8211884B2 (en) | 2008-08-06 | 2012-07-03 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| US20110224193A1 (en) * | 2008-11-19 | 2011-09-15 | Merck Sharp & Dohme Corp | Inhibitors of diacylglycerol acyltransferase |
| EP2367817A4 (en) | 2008-12-03 | 2012-05-09 | Via Pharmaceuticals Inc | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE |
| JP2012512252A (ja) | 2008-12-17 | 2012-05-31 | ブイアイエイ・ファーマシューティカルズ・インコーポレーテッド | ジアシルグリセロールアシルトランスフェラーゼの阻害剤 |
-
2009
- 2009-12-15 JP JP2011542339A patent/JP2012512252A/ja not_active Withdrawn
- 2009-12-15 EP EP09836834A patent/EP2378878A4/en not_active Withdrawn
- 2009-12-15 CA CA2745445A patent/CA2745445A1/en not_active Abandoned
- 2009-12-15 CN CN2009801505265A patent/CN102245024A/zh active Pending
- 2009-12-15 WO PCT/US2009/068048 patent/WO2010077861A1/en not_active Ceased
- 2009-12-15 AU AU2009333333A patent/AU2009333333A1/en not_active Abandoned
- 2009-12-15 US US12/638,244 patent/US8211914B2/en not_active Expired - Fee Related
-
2011
- 2011-05-26 IL IL213164A patent/IL213164A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2378878A4 (en) | 2012-08-01 |
| EP2378878A1 (en) | 2011-10-26 |
| AU2009333333A1 (en) | 2011-06-30 |
| CN102245024A (zh) | 2011-11-16 |
| US8211914B2 (en) | 2012-07-03 |
| WO2010077861A1 (en) | 2010-07-08 |
| JP2012512252A (ja) | 2012-05-31 |
| CA2745445A1 (en) | 2010-07-08 |
| US20100152445A1 (en) | 2010-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL212916A0 (en) | Inhibitors of diacylglycerol acyltransferase | |
| IL212496A0 (en) | Diacylglycerol acyltransferase inhibitors | |
| EP2378878A4 (en) | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | |
| EP2477498A4 (en) | INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE | |
| BR112012016178A2 (pt) | inibidores de diacilglicerol aciltransferase | |
| ZA201700326B (en) | Inhibitors of beta-secretase | |
| IL208656A0 (en) | Cyclic inhibitors of 11 beta-hydroxysteroid dehdrogenase 1 | |
| ZA201000829B (en) | Oxadiazole- and oxazole-substituted benzamidazole-and indole-derivatives as dgat1 inhibitors | |
| EP2370956A4 (en) | DYNAMIC DETAIL LEVEL | |
| SG10201404955RA (en) | Rnai inhibition of alpha-enac expression | |
| IL218018A0 (en) | Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions | |
| ZA201006719B (en) | Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases | |
| ZA201308664B (en) | Novel compounds as diacylglycerol acyltransferase inhibitors | |
| IL208212A0 (en) | Hydroxamate-based inhibitors of deacetylases b | |
| SMT201700523T1 (it) | Dispersioni contenenti inibitori di idrossifenilpiruvato-diossigenasi | |
| IL220187A0 (en) | Inhibitors of sphingosine kinase | |
| ZA201004765B (en) | Inhibitors of iap | |
| IL217720A0 (en) | Isoform selective phospholipase d inhibitors | |
| ZA201308569B (en) | Novel compounds as diacylglycerol acyltransferase inhibitors | |
| PL2411376T3 (pl) | Inhibitory nf-kb | |
| IL215249A0 (en) | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | |
| GB0808286D0 (en) | Inhibitors of HSP90 | |
| HK1195009A (en) | Novel compounds as diacylglycerol acyltransferase inhibitors | |
| ZA200908301B (en) | Rnai inhibition of alpha-enac expression | |
| HK1176856A (en) | Uses of dgat1 inhibitors |